Genetic testing for pancreatic cancer screening: ready for prime time?

Genetic testing is ready for prime time in PDAC screening. It stratifies patients into low-risk (no surveillance) and high-risk (surveillance warranted) groups, improving early detection, outcomes, and cost-effectiveness, thus transforming PDAC prognosis through targeted intervention.

Authors

David C. Whitcomb (ORCID: https://orcid.org/0000-0002-4462-1410)

Institutions

University of Pittsburgh (US)
Ofcom (GB)

Publication Details

Journal: Current Opinion in Gastroenterology
Published: 2025-07-14
DOI: https://doi.org/10.1097/mog.0000000000001121
Primary Topic: Pancreatic and Hepatic Oncology Research
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Genetic testing for pancreatic cancer screening: ready for prime time?

David C. Whitcomb

Jul 14, 2025

Current Opinion in Gastroenterology

Pancreatic and Hepatic Oncology Research

article

Genetic testing for pancreatic cancer screening: ready for prime time?

David C. Whitcomb

July 14, 2025article en

Abstract

Current Opinion in GastroenterologyVol. 41(5)

University of Pittsburgh (US), Ofcom (GB)

Good health and well-being

Openalex Percentile: Top 74%

Pancreatic and Hepatic Oncology Research

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Genetic testing for pancreatic cancer screening: ready for prime time? — David C. Whitcomb · Current Opinion in Gastroenterology (2025) | TGRS Research Map | TGRS